Takashi Kishimoto

No open positions remaining

66 year

Health Technology

Consumer Services

Profile

Takashi Kei Kishimoto worked as a Senior Director-Inflammation Research at Millennium Pharmaceuticals, Inc. from 1999 to 2006.
He then worked as an Associate Director-Research at Boehringer Ingelheim Corp.
before becoming the Vice President-Discovery Research at Momenta Pharmaceuticals, Inc. from 2006 to 2011.
He then became the Chief Scientific Officer at Selecta Biosciences, Inc. in 2011, where he worked until 2023.
He also worked as a Vice President-Research at Momenta Corp.
Dr. Kishimoto holds a doctorate degree from Harvard University and an undergraduate degree from New College of Florida.

Former positions of Takashi Kishimoto

Companies	Position	End
CARTESIAN THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	13/11/2023
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2011
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Corporate Officer/Principal	01/01/2006
Momenta Corp.	Chief Tech/Sci/R&D Officer	-
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Chief Tech/Sci/R&D Officer	-

See the detail of Takashi Kishimoto's experience

Training of Takashi Kishimoto

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Takashi Kishimoto's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases	Health Technology
Selecta Biosciences, Inc. Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New College of Florida New College of Florida Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Health Technology
Momenta Corp.